Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
KANGSTEM BIOTECH
★
Investor Relations Event to Enhance Understanding: Updates on Knee Osteoarthritis Drug OSCA Clinical Trials and Organoid Business
06/02/2026, 09:57 AM
PERI
KANGSTEM BIOTECH
★
Kangstem Biotech Q1 2026: Sales decline, operating loss improves; OSCA license deal with Yuyoung Pharma ongoing
05/14/2026, 04:19 PM